PetTech/Pet Care Capital Raises in the U.S. – March 1st – 15th, 2025
An interesting transaction closed in the PetTech/Pet Care sector over the past two weeks. If you would like more info on this deal or would like to discuss the capital raising market for your company, please contact me.
Petscreening, operator of a pet management platform intended to screen renters’ pets and validate the status of assistance animals, raised $80 million of Series B venture funding in a deal led by Volition Capital and Guidepost Growth Equit..
#castleplacement #capitalraising #privateequity #venturecapital #investment #PetTech #PetCare
Dominic Cipollone
Managing Director
Financial advisor for Morgan Stanley. Led seminars on investing and creating wealth. Met with small business owners to develop employee retirement plans. Advised clients on appropriate asset allocation investment strategies using the Dow 30. Over thirty years in the NYC Department of Education, including as Principal of one of the most challenging middle schools in the poorest districts in the country. Used educational-tech and targeted data to turn the school around. School was named a model for attendance improvement. Supported over two hundred school leaders. Believes ed-tech will reinvent how education is delivered and received. Masters of Science from Fordham University in Educational Leadership. Masters of Science from Iona College in Educational Technology. Bachelor of Arts from New York University in Political Science. FINRA Series 7, 63, and 79 licenses.
- Email: dcipollone@castleplacement.com
- (C) (203) 297-5089
 Dominic CipolloneManaging Director |
Please contact me if you have any questions or would like to discuss your capital raise:
Email: dcipollone@castleplacement.com
(C) (203) 297-5089
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement™ does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
